In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments

By Monnier Philippe P.   Vigouroux Robin J.   Tassew Nardos G.  

Antibodies, Vol. 2, Iss. 2, 2013-04 ,pp. : 193-208

MDPI

Access to resources Recommend Favorite

Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases

By Berges Nina   Hehmann-Titt Grit   Hristodorov Dmitrij   Melmer Georg   Thepen Theo   Barth Stefan  

Antibodies, Vol. 3, Iss. 1, 2014-02 ,pp. : 92-115

MDPI

Access to resources Recommend Favorite

Cell Penetrable Human scFv Specific to Middle Domain of Matrix Protein-1 Protects Mice from Lethal Influenza

By Dong-din-on Fonthip   Songserm Thaweesak   Pissawong Tippawan   Srimanote Potjanee   Thanongsaksrikul Jeeraphong   Thueng-in Kanyarat   Moonjit Pattra   Lertwatcharasarakul Preeda   Seesuay Watee   Chaicumpa Wanpen  

Viruses, Vol. 7, Iss. 1, 2015-01 ,pp. : 154-179

MDPI

Access to resources Recommend Favorite

Integrating scFv into xMAP Assays for the Detection of Marine Toxins

By Shriver-Lake Lisa C.   Liu Jinny L.   Brozozog Lee P. Audrey   Goldman Ellen R.   Dietrich Richard   Märtlbauer Erwin   Anderson George P.  

Toxins, Vol. 8, Iss. 11, 2016-11 ,pp. : 346-346

MDPI

Access to resources Recommend Favorite

Ophiophagus hannah Venom: Proteome, Components Bound by Naja kaouthia Antivenin and Neutralization by N. kaouthia Neurotoxin-Specific Human ScFv

By Danpaiboon Witchuda   Reamtong Onrapak   Sookrung Nitat   Seesuay Watee   Sakolvaree Yuwaporn   Thanongsaksrikul Jeeraphong   Dong-din-on Fonthip   Srimanote Potjanee   Thueng-in Kanyarat   Chaicumpa Wanpen  

Toxins, Vol. 6, Iss. 5, 2014-05 ,pp. : 1526-1558

MDPI

Access to resources Recommend Favorite